BE1005589A3 - Medicament pour le traitement de la dermatite. - Google Patents

Medicament pour le traitement de la dermatite. Download PDF

Info

Publication number
BE1005589A3
BE1005589A3 BE9100144A BE9100144A BE1005589A3 BE 1005589 A3 BE1005589 A3 BE 1005589A3 BE 9100144 A BE9100144 A BE 9100144A BE 9100144 A BE9100144 A BE 9100144A BE 1005589 A3 BE1005589 A3 BE 1005589A3
Authority
BE
Belgium
Prior art keywords
sep
nctc
medicament
bacterial lysate
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
BE9100144A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires OM SA
Original Assignee
Laboratoires OM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires OM SA filed Critical Laboratoires OM SA
Application granted granted Critical
Publication of BE1005589A3 publication Critical patent/BE1005589A3/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE9100144A 1990-02-16 1991-02-15 Medicament pour le traitement de la dermatite. Expired - Lifetime BE1005589A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH497/90A CH680045A5 (ja) 1990-02-16 1990-02-16

Publications (1)

Publication Number Publication Date
BE1005589A3 true BE1005589A3 (fr) 1993-11-16

Family

ID=4188357

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9100144A Expired - Lifetime BE1005589A3 (fr) 1990-02-16 1991-02-15 Medicament pour le traitement de la dermatite.

Country Status (13)

Country Link
JP (1) JP3002552B2 (ja)
KR (1) KR0169982B1 (ja)
AT (1) AT402152B (ja)
BE (1) BE1005589A3 (ja)
CH (1) CH680045A5 (ja)
DE (1) DE4104728C2 (ja)
EG (1) EG19540A (ja)
FR (1) FR2658419B1 (ja)
GB (1) GB2240922A (ja)
HU (1) HU210834B (ja)
IT (1) IT1244743B (ja)
PL (1) PL289084A1 (ja)
PT (1) PT96789B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098109C1 (ru) * 1996-09-26 1997-12-10 Александр Григорьевич Чучалин Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием
WO1999048510A1 (fr) * 1998-03-24 1999-09-30 Tayca Corporation Inhibiteur de la production d'anticorps d'immunoglobuline m et medicament contre la polyarthrite rhumatoide
EP2345421A1 (en) 2003-06-23 2011-07-20 Biotech Tools S.A. Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
UA72065C2 (en) * 2004-09-10 2005-01-17 Viridans Ltd Liability Company Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR102437436B1 (ko) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
JP7356742B2 (ja) * 2019-04-26 2023-10-05 エムディー ヘルスケア インコーポレイテッド ストレプトコッカスパイオジェネス細菌由来タンパク質及びその用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.

Also Published As

Publication number Publication date
KR0169982B1 (ko) 1999-02-01
HUT61201A (en) 1992-12-28
JP3002552B2 (ja) 2000-01-24
EG19540A (en) 1995-08-30
ITMI910381A1 (it) 1992-08-14
HU210834B (en) 1995-08-28
GB2240922A (en) 1991-08-21
CH680045A5 (ja) 1992-06-15
PT96789B (pt) 1998-08-31
IT1244743B (it) 1994-08-08
PT96789A (pt) 1991-10-31
ITMI910381A0 (it) 1991-02-14
HU910511D0 (en) 1991-09-30
GB9103278D0 (en) 1991-04-03
PL289084A1 (en) 1991-11-04
AT402152B (de) 1997-02-25
KR910015306A (ko) 1991-09-30
FR2658419A1 (fr) 1991-08-23
ATA32291A (de) 1996-07-15
DE4104728A1 (de) 1991-08-22
JPH04211017A (ja) 1992-08-03
FR2658419B1 (fr) 1995-01-27
DE4104728C2 (de) 1999-01-14

Similar Documents

Publication Publication Date Title
EP0088303B1 (fr) Procédé de préparation de complexes polysaccharide-protéine de capsules bactériennes, produits obtenus et compositions immunogènes les contenant
JPS58172319A (ja) 治療および診断用組成物
EP1615657A1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
BE1005589A3 (fr) Medicament pour le traitement de la dermatite.
Yu et al. Anticariogenic properties of the extract of Cyperus rotundus
LU86761A1 (fr) Compositions d'anticorps monoclonaux humains assurant la protection croisee
Yu et al. Asarum sieboldii extracts attenuate growth, acid production, adhesion, and water-insoluble glucan synthesis of Streptococcus mutans
FR2499854A1 (fr) Medicament contenant de la cyclodextrine utile notamment pour provoquer la proliferation des bifidobacteries intestinales
EP0071515B1 (fr) Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins
EP0016890A1 (fr) Nouvelle forme galénique d'administration de la bêtahistine
TW403655B (en) Novel attenuated pseudomonas aeruginosa strains
Pinheiro et al. Haemorrhagic syndrome of Altamira
RU2366708C2 (ru) Иммунобиологический бактерицидный препарат (варианты)
KR890004103B1 (ko) 치주염 억제용 항체의 제조방법
CA1229566A (fr) Procede de preparation du principe actif d'un medicament immunomodulateur
CH633188A5 (fr) Medicament contre des maladies infectieuses des voies respiratoires.
JP2001302480A (ja) チコリから活性化合物を溶媒抽出する方法
RU2262350C2 (ru) Вакцина для иммунопрофилактики и иммунотерапии заболеваний человека и животных, вызванных патогенными и условно-патогенными грамотрицательными микроорганизмами кишечной группы и их экзотоксинами, и способ ее получения (варианты), иммуноглобулиновый препарат (варианты) и способ его получения, иммунобиологический препарат, поликомпонентная вакцина
FR2702655A1 (fr) Composition thérapeutique nouvelle ayant un effet immunostimulant.
Jamieson et al. Bacillary Dysentery in Dundee: A Comparative Study of Treatments
JPH0255407B2 (ja)
Jensen et al. Alterations in Type and Bactericidal Activity of Mouse Peritoneal Phagocytes after Intraperitoneal Administration of Endotoxin
JPS6084302A (ja) アラビノガラクタンおよびその製法
FR2536281A1 (fr) Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires
Hunde et al. An In Vitro Evaluation of the Antibacterial Activity of Aloe barbadensis on Selected Bacterial Strains